The safety and efficacy of sequential intramuscular/oral ziprasidone treatment of acute episode in patients with schizophrenia: a multicenter, open-labeled study

BACKGROUND: Ziprasidone mesylate injection is an atypical antipsychotic drug which is recently approved in China. In combination with its oral formulation, sequential therapy with ziprasidone brings new interventions to patients with agitation in the acute phase of schizophrenia. The purpose of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yaxue, Li, Yanli, Liang, Weiye, Bai, Luyuan, Yu, Jianjin, Li, Keqing, Zhang, Yunshu, Guo, Yanmei, Liu, Zenglong, Wang, Jian, Zhang, Congpei, Wang, Xijin, Xu, Jia, Liu, Liping, Li, Juan, Yang, Fude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015911/
https://www.ncbi.nlm.nih.gov/pubmed/36922763
http://dx.doi.org/10.1186/s12888-023-04588-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015911/
https://www.ncbi.nlm.nih.gov/pubmed/36922763
http://dx.doi.org/10.1186/s12888-023-04588-0

Ejemplares similares